balance equationreview2017-01-31
Difference 729873000 exceeds tolerance 17584923.000. Presentation or filing-vintage differences need review.
Revenue
$41.52B
Fiscal year ended 2026-01-31Operating income
$8.33B
Fiscal year ended 2026-01-31Free cash flow
$14.40B
Fiscal year ended 2026-01-31Salesforce, Inc. (CRM) reported revenue of $41.52B and net income of $7.46B for the fiscal year ended 2026-01-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Salesforce, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Prepackaged Software.
Income
| Metric | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 | 2018-01-31 | 2017-01-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.52B | $37.90B | $34.86B | $31.35B | $26.49B | $21.25B | $17.10B | $13.28B | $10.54B | $8.44B |
| Cost of revenue | $9.27B | $8.64B | $8.54B | $8.36B | $7.03B | $5.44B | $4.24B | $3.45B | $2.77B | $2.23B |
| Gross profit | $32.26B | $29.25B | $26.32B | $22.99B | $19.47B | $15.81B | $12.86B | $9.83B | $7.77B | $6.20B |
| Operating income | $8.33B | $7.20B | $5.01B | $1.03B | $548.00M | $455.00M | $297.00M | $535.00M | $454.00M | $218.00M |
| Net income | $7.46B | $6.20B | $4.14B | $208.00M | $1.44B | $4.07B | $126.00M | $1.11B | $360.00M | $323.00M |
| Research & development | $5.99B | $5.49B | $4.91B | $5.06B | $4.46B | $3.60B | $2.77B | $1.89B | $1.55B | $1.21B |
| Weighted-average diluted shares | shares 956.00M | shares 974.00M | shares 984.00M | shares 997.00M | shares 974.00M | shares 930.00M | shares 850.00M | shares 775.00M | shares 735.00M | shares 700.00M |
| Pretax income | $9.52B | $7.44B | $4.95B | $660.00M | $1.53B | $2.56B | $706.00M | $983.00M | $420.00M | $179.00M |
| Income tax expense | $2.06B | $1.24B | $814.00M | $452.00M | $88.00M | -$1.51B | $580.00M | -$127.00M | $60.00M | -$144.00M |
| Diluted EPS | $7.80 | $6.36 | $4.20 | $0.21 | $1.48 | $4.38 | $0.15 | $1.43 | $0.49 | $0.46 |
| Selling, general & administrative | $17.34B | $16.09B | $15.41B | $16.08B | $14.45B | $11.76B | $9.63B | $7.41B | $5.76B | $4.78B |
| General & administrative | $3.00B | $2.84B | $2.53B | $2.55B | $2.60B | $2.09B | $1.70B | $1.35B | $1.09B | $966.00M |
| Selling & marketing | $14.34B | $13.26B | $12.88B | $13.53B | $11.86B | $9.67B | $7.93B | $6.06B | $4.67B | $3.81B |
Balance
| Metric | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 | 2018-01-31 | 2017-01-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $7.33B | $8.85B | $8.47B | $7.02B | $5.46B | $6.20B | $4.14B | $2.67B | $2.54B | $1.61B |
| Total assets | $112.30B | $102.93B | $99.82B | $98.85B | $95.21B | $66.30B | $55.13B | $30.74B | $21.98B | $17.58B |
| Current assets | $28.22B | $29.73B | $29.07B | $26.40B | $22.85B | $21.89B | $15.96B | $10.68B | $9.58B | $6.00B |
| Total liabilities | $53.16B | $41.76B | $40.18B | $40.49B | $37.08B | $24.81B | $21.24B | $15.13B | $11.61B | $10.08B |
| Current liabilities | $37.12B | $27.98B | $26.63B | $25.89B | $21.79B | $17.73B | $14.84B | $11.26B | $10.07B | $7.30B |
| Total equity incl. NCI | $59.14B | $61.17B | $59.65B | $58.36B | $58.13B | $41.49B | $33.88B | $15.60B | $10.38B | $8.23B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $3.87M | $0 |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $14.34B | $11.94B | $11.41B | $10.76B | $9.74B | $7.79B | $6.17B | $4.92B | $3.92B | $3.20B |
| Goodwill | $57.94B | $51.28B | $48.62B | $48.57B | $47.94B | $26.32B | $25.13B | $12.85B | $7.31B | $7.26B |
| Long-term debt | $10.44B | $8.43B | $8.43B | $9.42B | $10.59B | $2.67B | $2.67B | $3.17B | $695.00M | $2.01B |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $165.00M | $76.00M | $115.26M |
Cash flow
| Metric | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 | 2018-01-31 | 2017-01-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $15.00B | $13.09B | $10.23B | $7.11B | $6.00B | $4.80B | $4.33B | $3.40B | $2.74B | $2.16B |
| Capital expenditures | $594.00M | $658.00M | $736.00M | $798.00M | $717.00M | $710.00M | $643.00M | $595.00M | $534.00M | $464.00M |
| Investing cash flow | -$8.59B | -$3.16B | -$1.33B | -$1.99B | -$14.54B | -$3.97B | -$2.98B | -$5.31B | -$2.01B | -$2.68B |
| Financing cash flow | -$8.08B | -$9.43B | -$7.48B | -$3.56B | $7.84B | $1.19B | $164.00M | $2.01B | $221.00M | $998.00M |
| Net change in cash | -$1.52B | $376.00M | $1.46B | $1.55B | -$731.00M | $2.05B | $1.48B | $126.00M | $936.00M | $449.00M |
| Stock-based compensation | $3.51B | $3.18B | $2.79B | $3.28B | $2.78B | $2.19B | $1.78B | $1.28B | $997.00M | $820.00M |
| Common dividends paid | $1.59B | $1.54B | $0 | $0 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | $12.60B | $7.83B | $7.62B | $4.00B | $0 | $0 | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $1.20B | $1.00B | $1.10B | $903.00M | $678.00M | $579.00M | $455.00M | $411.00M | $373.00M | $632.00M |
Derived
| Metric | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 | 2018-01-31 | 2017-01-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $14.40B | $12.43B | $9.50B | $6.31B | $5.28B | $4.09B | $3.69B | $2.80B | $2.20B | $1.70B |
| Gross margin | 77.7% | 77.2% | 75.5% | 73.3% | 73.5% | 74.4% | 75.2% | 74.0% | 73.7% | 73.5% |
| Operating margin | 20.1% | 19.0% | 14.4% | 3.3% | 2.1% | 2.1% | 1.7% | 4.0% | 4.3% | 2.6% |
| FCF margin | 34.7% | 32.8% | 27.2% | 20.1% | 19.9% | 19.2% | 21.6% | 21.1% | 20.9% | 20.1% |
| SBC / revenue | 8.5% | 8.4% | 8.0% | 10.5% | 10.5% | 10.3% | 10.4% | 9.7% | 9.5% | 9.7% |
| Current ratio | 0.76x | 1.06x | 1.09x | 1.02x | 1.05x | 1.23x | 1.08x | 0.95x | 0.95x | 0.82x |
| Revenue YoY growth | 9.6% | 8.7% | 11.2% | 18.3% | 24.7% | 24.3% | 28.7% | 26.0% | 24.9% | Unavailable |
| Net margin | 18.0% | 16.4% | 11.9% | 0.7% | 5.5% | 19.2% | 0.7% | 8.4% | 3.4% | 3.8% |
| R&D / revenue | 14.4% | 14.5% | 14.1% | 16.1% | 16.9% | 16.9% | 16.2% | 14.2% | 14.7% | 14.3% |
| CapEx / revenue | 1.4% | 1.7% | 2.1% | 2.5% | 2.7% | 3.3% | 3.8% | 4.5% | 5.1% | 5.5% |
| Long-term debt / equity | 0.18x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 21.7% | 16.7% | 16.4% | 68.5% | 5.7% | -59.0% | 82.2% | -12.9% | 14.3% | -80.4% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CRM in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-27View SEC filing
10-Q · Filed 2026-05-28View SEC filing
10-K · Filed 2026-03-02View SEC filing
10-Q · Filed 2025-12-04View SEC filing
10-Q · Filed 2025-09-04View SEC filing
10-Q · Filed 2025-05-29View SEC filing
Reconciliation checks needing review
1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.